BIOLASE, Inc. (BIOL)
USD 0.02
(27.39%)
USD 0.02
(27.39%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 11.34 Million USD | 4.37% |
| 2022 | 10.86 Million USD | 172.85% |
| 2021 | -14.92 Million USD | -3867.68% |
| 2020 | 396 Thousand USD | -94.84% |
| 2019 | 7.67 Million USD | 174.96% |
| 2018 | 2.79 Million USD | 123.98% |
| 2017 | -11.64 Million USD | -32.86% |
| 2016 | -8.76 Million USD | 24.05% |
| 2015 | -11.54 Million USD | 63.43% |
| 2014 | -31.56 Million USD | -1088.41% |
| 2013 | 3.19 Million USD | 452.43% |
| 2012 | -906 Thousand USD | -32.26% |
| 2011 | -685 Thousand USD | -173.81% |
| 2010 | 928 Thousand USD | 131.19% |
| 2009 | -2.97 Million USD | 48.98% |
| 2008 | -5.83 Million USD | 47.06% |
| 2007 | -11.01 Million USD | 24.95% |
| 2006 | -14.67 Million USD | -348.53% |
| 2005 | -3.27 Million USD | 46.71% |
| 2004 | -6.14 Million USD | 27.17% |
| 2003 | -8.43 Million USD | -808.51% |
| 2002 | -928 Thousand USD | -5.69% |
| 2001 | -878 Thousand USD | -189.13% |
| 2000 | 985.1 Thousand USD | 512.08% |
| 1999 | 160.94 Thousand USD | -87.62% |
| 1998 | 1.3 Million USD | 1200.0% |
| 1997 | 100 Thousand USD | 133.33% |
| 1996 | -300 Thousand USD | 81.25% |
| 1995 | -1.6 Million USD | -33.33% |
| 1994 | -1.2 Million USD | 20.0% |
| 1993 | -1.5 Million USD | -87.5% |
| 1992 | -800 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 11.26 Million USD | -0.71% |
| 2024 Q2 | 9.37 Million USD | -16.79% |
| 2023 Q1 | 9.56 Million USD | -11.98% |
| 2023 FY | 11.34 Million USD | 4.37% |
| 2023 Q3 | 7.29 Million USD | -20.31% |
| 2023 Q2 | 9.15 Million USD | -4.34% |
| 2023 Q4 | 11.34 Million USD | 55.55% |
| 2022 Q3 | 4.87 Million USD | 205.18% |
| 2022 Q4 | 10.86 Million USD | 122.91% |
| 2022 FY | 10.86 Million USD | 172.85% |
| 2022 Q1 | -5.74 Million USD | 61.49% |
| 2022 Q2 | -4.63 Million USD | 19.32% |
| 2021 Q1 | -22.52 Million USD | -5787.12% |
| 2021 Q2 | -21.69 Million USD | 3.65% |
| 2021 FY | -14.92 Million USD | -3867.68% |
| 2021 Q3 | -17.91 Million USD | 17.46% |
| 2021 Q4 | -14.92 Million USD | 16.69% |
| 2020 Q2 | 11.24 Million USD | -7.74% |
| 2020 FY | 396 Thousand USD | -94.84% |
| 2020 Q1 | 12.19 Million USD | 58.8% |
| 2020 Q3 | -688 Thousand USD | -106.12% |
| 2020 Q4 | 396 Thousand USD | 157.56% |
| 2019 Q1 | 7.95 Million USD | 184.74% |
| 2019 Q3 | 11.26 Million USD | 17.25% |
| 2019 Q4 | 7.67 Million USD | -31.85% |
| 2019 FY | 7.67 Million USD | 174.96% |
| 2019 Q2 | 9.6 Million USD | 20.86% |
| 2018 Q3 | -688 Thousand USD | 75.56% |
| 2018 Q1 | -6.54 Million USD | 43.8% |
| 2018 FY | 2.79 Million USD | 123.98% |
| 2018 Q4 | 2.79 Million USD | 505.81% |
| 2018 Q2 | -2.81 Million USD | 56.99% |
| 2017 Q4 | -11.64 Million USD | -163.34% |
| 2017 FY | -11.64 Million USD | -32.86% |
| 2017 Q1 | -3.45 Million USD | 60.54% |
| 2017 Q2 | -7.84 Million USD | -126.71% |
| 2017 Q3 | -4.42 Million USD | 43.61% |
| 2016 FY | -8.76 Million USD | 24.05% |
| 2016 Q4 | -8.76 Million USD | 30.54% |
| 2016 Q3 | -12.61 Million USD | -172.29% |
| 2016 Q1 | -6.34 Million USD | 45.04% |
| 2016 Q2 | -4.63 Million USD | 26.93% |
| 2015 Q2 | -19.52 Million USD | 16.9% |
| 2015 Q1 | -23.49 Million USD | 25.54% |
| 2015 Q3 | -14.85 Million USD | 23.95% |
| 2015 FY | -11.54 Million USD | 63.43% |
| 2015 Q4 | -11.54 Million USD | 22.29% |
| 2014 Q2 | 1.22 Million USD | 17.07% |
| 2014 Q4 | -31.56 Million USD | -1043.89% |
| 2014 Q1 | 1.04 Million USD | -67.33% |
| 2014 FY | -31.56 Million USD | -1088.41% |
| 2014 Q3 | -2.75 Million USD | -325.96% |
| 2013 Q3 | 1.38 Million USD | -64.46% |
| 2013 Q2 | 3.89 Million USD | 91.49% |
| 2013 Q1 | 2.03 Million USD | 324.28% |
| 2013 FY | 3.19 Million USD | 452.43% |
| 2013 Q4 | 3.19 Million USD | 130.87% |
| 2012 Q2 | 328 Thousand USD | 111.83% |
| 2012 Q4 | -906 Thousand USD | -201.34% |
| 2012 Q1 | -2.77 Million USD | 16.18% |
| 2012 Q3 | 894 Thousand USD | 172.56% |
| 2012 FY | -906 Thousand USD | -32.26% |
| 2011 FY | -685 Thousand USD | -173.81% |
| 2011 Q2 | -10.13 Million USD | -520.96% |
| 2011 Q1 | -1.63 Million USD | -275.86% |
| 2011 Q3 | -5.75 Million USD | 43.19% |
| 2011 Q4 | -3.3 Million USD | 42.56% |
| 2010 Q4 | 928 Thousand USD | 37.08% |
| 2010 FY | 928 Thousand USD | 131.19% |
| 2010 Q3 | 677 Thousand USD | 9571.43% |
| 2010 Q2 | 7000.00 USD | 100.2% |
| 2010 Q1 | -3.42 Million USD | -15.23% |
| 2009 Q1 | -1.81 Million USD | 68.96% |
| 2009 Q2 | -3.48 Million USD | -92.65% |
| 2009 Q3 | -3.87 Million USD | -11.24% |
| 2009 Q4 | -2.97 Million USD | 23.3% |
| 2009 FY | -2.97 Million USD | 48.98% |
| 2008 Q2 | -14.5 Million USD | -21.82% |
| 2008 Q1 | -11.9 Million USD | -8.13% |
| 2008 Q4 | -5.83 Million USD | 47.35% |
| 2008 Q3 | -11.07 Million USD | 23.66% |
| 2008 FY | -5.83 Million USD | 47.06% |
| 2007 Q2 | -11.97 Million USD | 6.39% |
| 2007 FY | -11.01 Million USD | 24.95% |
| 2007 Q1 | -12.78 Million USD | 12.86% |
| 2007 Q3 | -11.89 Million USD | 0.68% |
| 2007 Q4 | -11.01 Million USD | 7.37% |
| 2006 Q4 | -14.67 Million USD | -155.41% |
| 2006 Q2 | -2.72 Million USD | -179.36% |
| 2006 FY | -14.67 Million USD | -348.53% |
| 2006 Q3 | -5.74 Million USD | -111.17% |
| 2006 Q1 | -974 Thousand USD | 70.23% |
| 2005 Q1 | -1.09 Million USD | 82.15% |
| 2005 Q4 | -3.27 Million USD | -13.45% |
| 2005 FY | -3.27 Million USD | 46.71% |
| 2005 Q3 | -2.88 Million USD | 65.26% |
| 2005 Q2 | -8.3 Million USD | -657.48% |
| 2004 FY | -6.14 Million USD | 27.17% |
| 2004 Q1 | -50.09 Million USD | -494.18% |
| 2004 Q2 | -5.37 Million USD | 89.27% |
| 2004 Q3 | -3.99 Million USD | 25.7% |
| 2004 Q4 | -6.14 Million USD | -53.77% |
| 2003 FY | -8.43 Million USD | -808.51% |
| 2003 Q4 | -8.43 Million USD | -169.96% |
| 2003 Q3 | -3.12 Million USD | 11.33% |
| 2003 Q2 | -3.52 Million USD | -27.52% |
| 2003 Q1 | -2.76 Million USD | -197.63% |
| 2002 Q4 | -928 Thousand USD | -6286.67% |
| 2002 Q3 | 15 Thousand USD | -96.03% |
| 2002 Q1 | 323 Thousand USD | 136.79% |
| 2002 FY | -928 Thousand USD | -5.69% |
| 2002 Q2 | 378 Thousand USD | 17.03% |
| 2001 Q2 | -1.71 Million USD | -131.09% |
| 2001 Q1 | -742.29 Thousand USD | -175.35% |
| 2001 Q4 | -878 Thousand USD | -44.41% |
| 2001 Q3 | -608 Thousand USD | 64.56% |
| 2001 FY | -878 Thousand USD | -189.13% |
| 2000 Q3 | 1.67 Million USD | 201.41% |
| 2000 Q1 | -2.41 Million USD | -1597.51% |
| 2000 Q2 | -1.65 Million USD | 31.44% |
| 2000 Q4 | 985.1 Thousand USD | -41.22% |
| 2000 FY | 985.1 Thousand USD | 512.08% |
| 1999 Q3 | -100 Thousand USD | 80.0% |
| 1999 FY | 160.94 Thousand USD | -87.62% |
| 1999 Q4 | 160.94 Thousand USD | 260.94% |
| 1999 Q1 | -1.6 Million USD | -223.08% |
| 1999 Q2 | -500 Thousand USD | 68.75% |
| 1998 Q2 | 400 Thousand USD | -66.67% |
| 1998 Q1 | 1.2 Million USD | 1100.0% |
| 1998 FY | 1.3 Million USD | 1200.0% |
| 1998 Q3 | 1.2 Million USD | 200.0% |
| 1998 Q4 | 1.3 Million USD | 8.33% |
| 1997 Q1 | -500 Thousand USD | -66.67% |
| 1997 FY | 100 Thousand USD | 133.33% |
| 1997 Q2 | -300 Thousand USD | 40.0% |
| 1997 Q3 | -300 Thousand USD | 0.0% |
| 1997 Q4 | 100 Thousand USD | 133.33% |
| 1996 Q4 | -300 Thousand USD | -200.0% |
| 1996 Q3 | -100 Thousand USD | 83.33% |
| 1996 Q2 | -600 Thousand USD | 45.45% |
| 1996 FY | -300 Thousand USD | 81.25% |
| 1996 Q1 | -1.1 Million USD | 31.25% |
| 1995 Q2 | -1.1 Million USD | -175.0% |
| 1995 Q1 | -400 Thousand USD | 66.67% |
| 1995 Q3 | -1.8 Million USD | -63.64% |
| 1995 Q4 | -1.6 Million USD | 11.11% |
| 1995 FY | -1.6 Million USD | -33.33% |
| 1994 Q2 | -500 Thousand USD | 0.0% |
| 1994 Q4 | -1.2 Million USD | 29.41% |
| 1994 FY | -1.2 Million USD | 20.0% |
| 1994 Q3 | -1.7 Million USD | -240.0% |
| 1993 Q1 | 400 Thousand USD | 150.0% |
| 1993 Q2 | 1.5 Million USD | 275.0% |
| 1993 Q3 | 600 Thousand USD | -60.0% |
| 1993 FY | -1.5 Million USD | -87.5% |
| 1993 Q4 | -1.5 Million USD | -350.0% |
| 1992 Q4 | -800 Thousand USD | -300.0% |
| 1992 FY | -800 Thousand USD | 0.0% |
| 1992 Q2 | -500 Thousand USD | 0.0% |
| 1992 Q3 | 400 Thousand USD | 180.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 27.08 Million USD | 58.112% |
| BrainsWay Ltd. | -10.32 Million USD | 209.922% |
| Cerus Corporation | 84.35 Million USD | 86.552% |
| Envoy Medical, Inc. | -3.81 Million USD | 397.431% |
| electroCore, Inc. | -9.95 Million USD | 213.953% |
| Helius Medical Technologies, Inc. | -5.12 Million USD | 321.346% |
| IceCure Medical Ltd | -9.93 Million USD | 214.194% |
| Inogen, Inc. | -103.56 Million USD | 110.953% |
| OrthoPediatrics Corp. | -9.26 Million USD | 222.413% |
| Lucid Diagnostics Inc. | -3.64 Million USD | 411.563% |
| Monogram Orthopaedics, Inc. | -13.09 Million USD | 186.615% |
| MaxCyte, Inc. | -27.76 Million USD | 140.86% |
| NeuroOne Medical Technologies Corporation | -5.13 Million USD | 320.782% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | 2070.241% |
| Orthofix Medical Inc. | 96.44 Million USD | 88.237% |
| PAVmed Inc | 29.08 Million USD | 60.998% |
| Rapid Micro Biosystems, Inc. | -16.93 Million USD | 166.97% |
| RxSight, Inc. | -6.68 Million USD | 269.82% |
| Sight Sciences, Inc. | -102.71 Million USD | 111.044% |
| SI-BONE, Inc. | 5.72 Million USD | -98.287% |
| TELA Bio, Inc. | -3.94 Million USD | 387.263% |
| Treace Medical Concepts, Inc. | 57.32 Million USD | 80.21% |
| Vivos Therapeutics, Inc. | 352 Thousand USD | -3122.727% |
| Acutus Medical, Inc. | 12.27 Million USD | 7.615% |
| Talis Biomedical Corporation | -57.06 Million USD | 119.879% |
| Spectral AI, Inc. | -3.5 Million USD | 424.022% |
| Nano-X Imaging Ltd. | -48.02 Million USD | 123.62% |
| CVRx, Inc. | -59.95 Million USD | 118.921% |
| DIH Holding US, Inc. Warrants | 1.98 Million USD | -471.732% |
| PetVivo Holdings, Inc. | 1.27 Million USD | -787.889% |
| Bioventus Inc. | 372.51 Million USD | 96.955% |
| Venus Concept Inc. | 74.3 Million USD | 84.732% |
| TriSalus Life Sciences, Inc. | -10.18 Million USD | 211.412% |
| LivaNova PLC | 62.53 Million USD | 81.859% |
| 908 Devices Inc. | -115.09 Million USD | 109.856% |
| Alphatec Holdings, Inc. | 320.7 Million USD | 96.463% |
| Nemaura Medical Inc. | 9.92 Million USD | -14.297% |
| NeuroPace, Inc. | 54.33 Million USD | 79.123% |
| LENSAR, Inc. | -18.31 Million USD | 161.948% |
| Apyx Medical Corporation | -5.15 Million USD | 320.229% |
| Cutera, Inc. | 288.3 Million USD | 96.065% |
| STRATA Skin Sciences, Inc. | 7.51 Million USD | -50.951% |
| BioSig Technologies, Inc. | 262 Thousand USD | -4229.771% |
| Anika Therapeutics, Inc. | -43.83 Million USD | 125.882% |
| ClearPoint Neuro, Inc. | -9.19 Million USD | 223.318% |
| Integra LifeSciences Holdings Corporation | 1.4 Billion USD | 99.193% |
| Axonics, Inc. | -77.19 Million USD | 114.695% |
| Outset Medical, Inc. | 67.67 Million USD | 83.239% |
| IRIDEX Corporation | -4.28 Million USD | 364.552% |
| PROCEPT BioRobotics Corporation | -178.01 Million USD | 106.372% |
| IRadimed Corporation | -47.71 Million USD | 123.772% |
| Tivic Health Systems, Inc. | -3.02 Million USD | 474.884% |
| INVO Bioscience, Inc. | 8.45 Million USD | -34.23% |
| Telesis Bio, Inc. | 32.63 Million USD | 65.24% |
| Viemed Healthcare, Inc. | -2.5 Million USD | 553.373% |
| Varex Imaging Corporation | 316.9 Million USD | 96.42% |
| Quipt Home Medical Corp. | 81.73 Million USD | 86.121% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | 507.764% |
| Pulmonx Corporation | -42.36 Million USD | 126.78% |
| Dynatronics Corporation | 6.2 Million USD | -82.849% |
| Modular Medical, Inc. | -8.04 Million USD | 241.059% |
| ReShape Lifesciences Inc. | -4.29 Million USD | 363.998% |
| Semler Scientific, Inc. | -57.13 Million USD | 119.856% |
| InMode Ltd. | -135.39 Million USD | 108.379% |
| Bruker Corporation | 891.3 Million USD | 98.727% |
| Cytosorbents Corporation | 4.18 Million USD | -171.257% |
| DexCom, Inc. | 2.02 Billion USD | 99.441% |
| Align Technology, Inc. | -840.47 Million USD | 101.35% |
| Viveve Medical, Inc. | -13.81 Million USD | 182.126% |
| ZimVie Inc. | 450.41 Million USD | 97.481% |
| Movano Inc. | -5.86 Million USD | 293.386% |
| Cytek Biosciences, Inc. | -134.45 Million USD | 108.437% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | 2070.241% |
| DIH Holdings US, Inc. Class A Common Stock | 1.98 Million USD | -471.732% |
| Tandem Diabetes Care, Inc. | 356.79 Million USD | 96.821% |
| Profound Medical Corp. | -18.17 Million USD | 162.403% |
| Insulet Corporation | 798.1 Million USD | 98.579% |
| enVVeno Medical Corporation | -2.21 Million USD | 611.452% |
| Surmodics, Inc. | -12.01 Million USD | 194.423% |
| iCAD, Inc. | -21.2 Million USD | 153.487% |
| Nuwellis, Inc. | -2.81 Million USD | 502.412% |
| Biotricity, Inc. | 23.09 Million USD | 50.876% |
| iRhythm Technologies, Inc. | 93.65 Million USD | 87.887% |
| Aethlon Medical, Inc. | -4.5 Million USD | 351.996% |
| InspireMD, Inc. | -8.04 Million USD | 241.007% |
| PAVmed Inc. | 29.08 Million USD | 60.998% |
| Beyond Air, Inc. | 6.22 Million USD | -82.116% |
| FONAR Corporation | -14.66 Million USD | 177.353% |
| AxoGen, Inc. | 32.26 Million USD | 64.842% |
| Vivani Medical, Inc. | 42 Thousand USD | -26909.524% |
| Tactile Systems Technology, Inc. | -10.65 Million USD | 206.436% |
| Inari Medical, Inc. | -7.16 Million USD | 258.414% |
| UFP Technologies, Inc. | 40.77 Million USD | 72.178% |
| QT Imaging Holdings, Inc. | 3.06 Million USD | -269.677% |
| Heart Test Laboratories, Inc. | -4.77 Million USD | 337.754% |
| Tenon Medical, Inc. | -1.25 Million USD | 1003.904% |
| Autonomix Medical, Inc. Common Stock | -7.6 Million USD | 249.145% |
| Co-Diagnostics, Inc. | -11.92 Million USD | 195.117% |
| AdaptHealth Corp. | 2.21 Billion USD | 99.488% |
| Sintx Technologies, Inc. | 905 Thousand USD | -1153.481% |
| NanoVibronix, Inc. | -3.27 Million USD | 446.065% |
| Quanterix Corporation | -132.95 Million USD | 108.532% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | 507.764% |
| Sensus Healthcare, Inc. | -22.36 Million USD | 150.722% |
| Pacific Biosciences of California, Inc. | 753.71 Million USD | 98.495% |
| TransMedics Group, Inc. | 121.13 Million USD | 90.635% |
| ReWalk Robotics Ltd. | -26.18 Million USD | 143.331% |
| NeuroMetrix, Inc. | -1.49 Million USD | 860.796% |
| Hyperfine, Inc. | -75.61 Million USD | 115.002% |
| Establishment Labs Holdings Inc. | 152.18 Million USD | 92.546% |
| Biomerica, Inc. | -3.38 Million USD | 435.126% |
| Bone Biologics Corporation | -3.02 Million USD | 474.814% |
| AVITA Medical, Inc. | -26.23 Million USD | 143.246% |
| Bluejay Diagnostics, Inc. | -1.83 Million USD | 717.055% |
| Silk Road Medical, Inc | 64.42 Million USD | 82.391% |